Newsbot Nachrichten

Defensive Stocks Rotation Ahead Of NFP - Index Outlook And NFP Trading Levels

Soren Acquisition Corp. Announces Closing of $253 Million Initial Public Offering

Miami, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Soren Acquisition Corp. (the “Company”) announced today the closing of its initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $253,000,000.

JCPenney is selling a $142 farmhouse comforter set for just $39

Shoppers say its "so soft and comfortable."

NYT Pips Today: Hints, Answers And Full Solution For Friday, January 9

Looking for help with todays New York Times Pips? Well walk you through todays puzzle and help you match dominoes to tiles.

EICC: Attractive CEF Liabilities After The Refinancing

WD-40 Company (WDFC) Q1 2026 Earnings Call Transcript

Why Costco Stock Popped Today

The retail titans sales are growing at an impressive clip.

Kinaxis ernennt Razat Gaurav zum neuen CEO

OTTAWA, Ontario, Kanada--(BUSINESS WIRE)--Kinaxis® Inc. (TSX:KXS), ein weltweit führender Anbieter im Bereich der Supply-Chain-Orchestrierung, gab heute die Ernennung von Herrn Razat Gaurav zum Chief Executive Officer (CEO) mit Wirkung zum 12. Januar 2026 bekannt. Zu seinem offiziellen Amtsantritt wird er außerdem Mitglied des Board of Directors von Kinaxis. „Nach einer intensiven Suche hat sich das Board für Razat als neuen CEO entschieden“, erklärt Bob Courteau, Interim-CEO und Board Chair be

Tim Burchett Reacts To Senate Advancing Venezuela War Powers Resolution

Rep. Burchett discussed on "Forbes Newsroom" the Senate advancing a bipartisan war powers resolution that would block Trump from further military action in Venezuela.

Lucid Doubled Its Vehicle Production in 2025. Its Still Not Time to Buy the Stock.

Lucids vehicle production increase is impressive, but the company is burning through cash and doesnt have a clear path for success.

Apple: Time To Get Out

Outsized Gains: Factors That Determine Stock Outperformance

When it comes to outperformance, several factors, including robust sales growth, margin expansion, innovation, and favorable earnings estimate revisions, are all contributing factors.

NYT Strands Hints, Spangram, Answers: Friday, January 9 (For Cubs Fans)

Looking for help with todays NYT Strands puzzle? Heres an extra hint to help you uncover the right words, as well as all of todays answers and Spangram.

Jack Henry & Associates: Reliable Compounder, Solid Outlook

Best Growth Stocks to Buy for January 9th

CIEN and CMC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 9th, 2026.

Enterprise Products Up 6% in a Year: Time to Bet on the Stock or Wait?

EPD beat its industry with a 6% yearly gain, backed by inflation-linked contracts and capital returns, but valuation and leverage argue for patience.

3 Stocks With Upgraded Broker Ratings to Buy for Solid Returns in 2026

Broker upgrades make TripAdvisor, Marathon Petroleum and J.B. Hunt Transport top picks for 2026, with strong earnings growth on the horizon.

Salesforce Plunges 20% in a Year: Is CRM Stock Still a Hold?

CRM shares are down 18% in a year, but AI momentum, enterprise expansion and discounted valuation suggest Salesforce may still be worth holding.

Will Accelerating AWS Revenue Growth Drive AMZN Stocks 2026 Rally?

Amazons AWS posts its fastest growth since 2022 as AI demand surges, with a $200 billion backlog and heavy investment fueling 2026 optimism.

3 MedTech Stocks That Crushed the S&P 500 Over the Past Year

TransMedics, KORU Medical Systems and Cardinal Health beat the S&P 500 as execution, earnings visibility and company-specific catalysts drove gains.

Goldman Projects 46-Cent EPS Gain in Q4 From Apple Card Transition

GS expects a 46-cent EPS boost in 4Q25 as it exits the Apple Card, releasing reserves amid a 24-month transition of the program to JPMorgan.

Heres What We Expect From AbbVies Immunology Segment in Q4

ABBVs Q4 outlook hinges on surging Skyrizi and Rinvoq demand, as investors watch immunology sales to offset Humiras past loss of exclusivity.

XOMs Integrated Business Model Shields Earnings Amid Lower Oil Prices

ExxonMobil warns that upstream earnings face pressure from lower oil prices, but its integrated model boosts refining gains to cushion profitability.

UBER vs. BIDU: Which Stock Is Better Placed in the Promising AV Space?

Baidu edges ahead of Uber in the AV race, backed by global robotaxi rollout, stronger earnings outlook and valuation.

Best Income Stocks to Buy for January 9th

ACRE, STEP and ADEA made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 9th, 2026.

SLP Stock Crashes on Q1 Earnings Miss, Software Headwinds Hurt Sales

Simulations Plus Q1 fiscal 2026 EPS miss as software revenue fall 17%, but services momentum and strong bookings support confidence for the rest of fiscal 2026.

The Stock-Market Rally Isn’t Just About Tech Anymore

Hopes for an economic reacceleration are helping to fuel a “rotation trade.”

New Strong Buy Stocks for January 9th

BDTX, LUMN, ADEA, ACRE and TACT have been added to the Zacks Rank #1 (Strong Buy) List on January 9th, 2026.

HELE Q3 Earnings Meet Estimates, Home & Outdoor Sales Decline Y/Y

HELEs third-quarter earnings meet estimates as sales decline year over year, with Home & Outdoor weakness partly offset by Olive & June growth.

3 Construction & Mining Equipment Stocks to Watch Despite Industry Headwinds

The Zacks Industry Rank for the Manufacturing - Construction and Mining industry paints a dull picture. We believe that stocks like CAT, TEX and ASTE are still worth a look.

ADI Climbs 35.7% in a Year: Should You Buy, Sell or Hold the Stock?

Analog Devices shares surge 35.7% in a year as AI-driven demand lifts industrial and communications growth, boosts data center sales and supports strong margins.

Looking for a Growth Stock? 3 Reasons Why Commercial Metals (CMC) is a Solid Choice

Commercial Metals (CMC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

JPM Q4 Earnings on Deck: Buy, Sell or Hold the Stock Ahead of Results?

JPMorgans Q4 earnings preview shows strength in trading and lending, but expenses and valuation may weigh on investor sentiment.

Salesforce Plunges 20% in a Year: Is the CRM Stock Still a Hold?

CRM shares are down 18% in a year, but AI momentum, enterprise expansion and discounted valuation suggest Salesforce may still be worth holding.

Oil Services ETF (OIH) Hits New 52-Week High

OIH hits a fresh 52-week high as oil prices stay firm and momentum builds. Can the rally last amid high risk?

3 Medical Service Industry Stocks Set to Tackle Workforce Challenges

Medical services stocks like MEDP, EHAB and PGNY benefit from tech-driven care models even as staffing gaps pressure margins.

Kratos Defense Stock Rises 35.3% in a Month: Heres How to Play

KTOS has jumped 35.3% in a month on contract wins and rising unmanned system demand, but weaker ROIC and sector risks complicate the entry timing.

Betting on a Boom: 3 Healthcare ETFs for 2026 and Beyond

After a late-2025 rebound eased policy fears, healthcare ETFs like IXJ are gaining attention as investors position for a sector comeback in 2026.

Verizon Outpaces Its Industry in a Year: How to Play the Stock?

VZ has outpaced its wireless industry over the past year as 5G upgrades, network slicing and new partnerships fuel growth despite debt and competition.

Ondas Up Nearly 600% in the Past Six Months: How to Play the Stock?

ONDS has surged nearly 600% in six months as it pivots to autonomous systems, but soaring costs and valuation raise exit questions.

Best Value Stocks to Buy for January 9th

ACRE made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 9th, 2026.

4 Top-Ranked Tech Stocks to Buy as Semiconductor Rally Continues

Semiconductor sales hit a record in November, with NVDA, MU, CRDO and ASYS set to gain from booming AI demand.

BMY Rallies 17.3% in Six Months: Buy, Sell or Hold the Stock?

BMY shares have surged in the past six months, driven by Opdivo, Reblozyl and a guidance raise, as growth drugs offset mounting generic pressure

Merck in Talks to Buy Revolution Medicines Per Financial Times Report

Merck is in talks to acquire RVMD, which could bolster its oncology pipeline, according to a Financial Times report.

Gold Steadies as Mixed US Data Dims Fed Rate-Cut Bets This Month

Gold steadied as traders maintained expectations that the Federal Reserve will hold rates steady at their January meeting, after key US jobs data gave mixed signals about the health of the US economy.

NASA to bring Space Station astronauts back to Earth weeks early due to medical situation

NASA earlier delayed a planned spacewalk with ISS Commander Mike Fincke and flight engineer Zena Cardman.

Lumos Diagnostics Holdings Limited (LDXHF) Shareholder/Analyst Call Transcript

Trump Has ‘No Plan’ For Venezuela After Maduros Capture: Debbie Wasserman Schultz

Rep. Debbie Wasserman Schultz (D-FL) joined "Forbes Newsroom" to discuss whats next following the capture of Venezuelan President Nicolás Maduro by U.S. forces.

Why Tilray Brands Stock Is Rising in After-Hours Trading

Tilray had good things to say about its recent quarter -- and investors were listening.

Job Openings Fall To 14-Month Low

Booz Allen Hamilton: A Much More Constructive Environment In 2026

Jim Cramer says the market rotation is punishing last year’s winners and reviving beaten-down stocks

Jim Cramer said investors are witnessing a classic market rotation, as capital flows from last year’s biggest winners into stocks that had fallen out of favor.

3 Millionaire-Maker Artificial Intelligence (AI) Stocks

You dont have to buy risky stocks to invest in the AI boom.

Ryoncil® Sales Increase 60% in December Quarter to US$35.1M

Strong Balance Sheet Reflects Revenue Growth and New $125M Five-Year Facility Strong Balance Sheet Reflects Revenue Growth and New $125M Five-Year Facility

Ukraine Awards Major Lithium Project to Investors With Links to Trump

Ronald S. Lauder, a billionaire friend of Mr. Trump, is among the investors. The move comes as the Trump administration looks to profit from investment opportunities in Ukraine.

Wall Street strategist reveals game plan for 2026

Sam Stovall has been navigating stocks for a long time. Stovall is the Chief Investment Strategist at CFRA, and his stock market experience is rooted in over 30 years of tracking markets, dating back to his tenure as managing director and chief investment strategist at S&P Global and ...

IRW-News: Lir Life Sciences Corp.: LIR Life engagiert Neuland Labs, um die Entwicklung zelldurchdringender Peptide für die transdermale GLP-1/GIP-Plattform voranzutreiben

IRW-PRESS: Lir Life Sciences Corp.: LIR Life engagiert Neuland Labs, um die Entwicklung zelldurchdringender Peptide für die transdermale GLP-1/GIP-Plattform voranzutreibenVancouver, Kanada - 8. Januar 2026 / IRW-Press / LIR Life Sciences Corp. (CSE: ...